Revolution Medicines is a integral, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide.
Our people are united by a shared way of working: follow the science, challenge assumptions, act with urgency and hold ourselves to a high standard of rigor-all in service of patients.
The Opportunity:
The Associate Director, Market Access HTA, Spain is responsible for defining and executing the market access strategy to ensure timely, sustainable patient access to innovative oncology therapies. Working closely with the Senior Director, Market Access HTA, in Spain,
this role helps to shape business strategies, drives value demonstration, and leads engagement with key external stakeholders including payers, HTA bodies, and health authorities, both at national and regional level
Responsibilities:
- Market Access & Reimbursement: Develop and implement strategies to support access and pricing decisions for oncology products within the Spanish healthcare system
- HTA & Pricing Filings: Lead preparation and submission of value dossiers, and pricing negotiations with MoH and regional HTAs
- Value Communication: Translate clinical and economic evidence into compelling value communications tailored for Spanish payers.
- External Stakeholder Engagement: Build and maintain strong relationships with key external stakeholders (regional payers and policy maker authorities)
- Identify and prioritize key stakeholders focus on HE with influence in HTAs process.
- Effectively en